Key Drivers
- Margin Expansion
- Strong Cash Flow
- High Debt Load
AIAI Summary
CON should now be viewed less as a defensive healthcare name and more as a levered, self-funding growth story: the quarter showed simultaneous revenue, margin, EBITDA, and cash-flow expansion that supports dividends/buybacks, but the stock only works if management sustains organic growth and margin gains because leverage and valuation leave little room for execution missteps.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Expansion
- •Strong Cash Flow
- •High Debt Load
CON's profitability and cash generation are improving, but heavy leverage, sizable intangibles, and a valuation that already reflects solid performance make the risk/reward only moderate.
Price Behavior
Key Price Behavior Insights:
- •Breakout Hold
- •Higher Highs
- •Stretch Risk
CON is up about 12% over the last month after a sharp breakout above $34.00, with higher highs keeping momentum positive, though the move is stretched and a pullback to $34.00–$33.03 would be normal.
Sharp jump from $30.54 to $34.06 signals a fast breakout and short-term volatility risk
Sentiment & News
Key News Insights:
- •Q2 beat
- •Idaho expansion
- •CEO transition
CON saw broadly positive late-summer updates, led by Concentra's strong Q2 beat-and-raise, Idaho expansion, and leadership transition, while Con Edison also posted higher Q2 earnings and maintained its dividend.
The news is mildly bullish for CON, as stronger operating momentum and shareholder returns support sentiment despite the planned management change
Similar Companies in Healthcare
Other companies in the same sector with AI ratings